ArticleMaterials today. Bio2026
Conductive ionic liquid hydrogel filled anti-inflammatory nerve conduit repairs peripheral nerve defect.
Article in Materials today. Bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Conductive and anti-inflammatory microenvironments have been proven effective for peripheral nerve repair. Herein, a conductive chitosan-hydroxyethyl cellulose/ionic liquid (CS-HEC/IL) hydrogel was constructed, which was injected into a hollow anti-inflammatory poly(L-lactide-co-caprolactone)/luteolin (PLCL/Lut) nanofiber conduit. Such a PLCL/Lut-CS-HEC/IL conduit greatly enhanced the proliferation of Schwann and PC12 cells, andpromotedmacrophage transition to the M2 phenotype. Following implantation into a 10 mm sciatic nerve defect in a rat model, the scaffold was harvested 8 weeks post-surgery for histological and functional assessment. Histological analysis revealed that the conduit markedly enhanced nerve regeneration, as indicated by extensive myelination and axonal outgrowth, while functional assessments indicated improved motor recovery and nerve conduction, highlighting its therapeutic potential. Generally, the PLCL/Lut-CS-HEC/IL scaffold is a promising therapeutic strategy for peripheral nerve injuries.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.